Literature DB >> 33558655

Bile duct ligation causes opposite impacts on the expression and function of BCRP and P-gp in rat brain partly via affecting membrane expression of ezrin/radixin/moesin proteins.

Tong Wu1, Yun Sheng1, Yuan-Yuan Qin1, Wei-Min Kong1, Meng-Meng Jin1, Han-Yu Yang1, Xiao-Ke Zheng1, Chang Dai1, Ming Liu1, Xiao-Dong Liu2, Li Liu3.   

Abstract

Breast cancer resistance protein (BCRP) and P-glycoprotein (P-gp) are co-located at blood-brain barrier (BBB) cells, preventing their substrates from entering brain. Accumulating evidence demonstrates that liver failure impairs P-gp and BCRP expression and function in the brain. In the current study, we investigated how liver failure influenced the expression and function of brain BCRP and P-gp in rats subjected to bile duct ligation (BDL). The function of BCRP, P-gp and BBB integrity was assessed using distribution of prazosin, rhodamine 123 and fluorescein, respectively. We showed that BDL significantly decreased BCRP function, but increased P-gp function without affecting BBB integrity. Furthermore, we found that BDL significantly downregulated the expression of membrane BCRP and upregulated the expression of membrane P-gp protein in the cortex and hippocampus. In human cerebral microvascular endothelial cells, NH4Cl plus unconjugated bilirubin significantly decreased BCRP function and expression of membrane BCRP protein, but upregulated P-gp function and expression of membrane P-gp protein. The decreased expression of membrane BCRP protein was linked to the decreased expression of membrane radixin protein, while the increased expression of membrane P-gp protein was related to the increased location of membrane ezrin protein. Silencing ezrin impaired membrane location of P-gp, whereas silencing radixin impaired membrane location of BCRP protein. BDL rats showed the increased expression of membrane ezrin protein and decreased expression of membrane radixin protein in the brain. We conclude that BDL causes opposite effects on the expression and function of brain BCRP and P-gp, attributing to the altered expression of membrane radixin and ezrin protein, respectively, due to hyperbilirubinemia and hyperammonemia.
© 2021. The Author(s), under exclusive licence to CPS and SIMM.

Entities:  

Keywords:  ERM proteins; P-glycoprotein; blood-brain barrier; breast cancer resistance protein; liver failure

Mesh:

Substances:

Year:  2021        PMID: 33558655      PMCID: PMC8563881          DOI: 10.1038/s41401-020-00602-3

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   7.169


  43 in total

Review 1.  Drug efflux transporters in the CNS.

Authors:  Haiying Sun; Haiqing Dai; Naveed Shaik; William F Elmquist
Journal:  Adv Drug Deliv Rev       Date:  2003-01-21       Impact factor: 15.470

Review 2.  Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders.

Authors:  Eva Gil-Martins; Daniel José Barbosa; Vera Silva; Fernando Remião; Renata Silva
Journal:  Pharmacol Ther       Date:  2020-04-19       Impact factor: 12.310

3.  Acute liver failure impairs function and expression of breast cancer-resistant protein (BCRP) at rat blood-brain barrier partly via ammonia-ROS-ERK1/2 activation.

Authors:  Ying Li; Ji Zhang; Ping Xu; Binbin Sun; Zeyu Zhong; Can Liu; Zhaoli Ling; Yang Chen; Nan Shu; Kaijing Zhao; Li Liu; Xiaodong Liu
Journal:  J Neurochem       Date:  2016-05-30       Impact factor: 5.372

Review 4.  Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation.

Authors:  Dominic R Aldridge; Edward J Tranah; Debbie L Shawcross
Journal:  J Clin Exp Hepatol       Date:  2014-06-30

Review 5.  Potential Regulation Mechanisms of P-gp in the Blood-Brain Barrier in Hypoxia.

Authors:  Yidan Ding; Rong Wang; Jianchun Zhang; Anpeng Zhao; Hui Lu; Wenbin Li; Chang Wang; Xuechun Yuan
Journal:  Curr Pharm Des       Date:  2019       Impact factor: 3.116

Review 6.  Contributions of Drug Transporters to Blood-Brain Barriers.

Authors:  Li Liu; Xiaodong Liu
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 7.  An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: further studies using NMR spectroscopy.

Authors:  Claudia Zwingmann; Roger Butterworth
Journal:  Neurochem Int       Date:  2005-07       Impact factor: 3.921

8.  Unconjugated bilirubin elevation impairs the function and expression of breast cancer resistance protein (BCRP) at the blood-brain barrier in bile duct-ligated rats.

Authors:  Ping Xu; Zhao-Li Ling; Ji Zhang; Ying Li; Nan Shu; Ze-Yu Zhong; Yang Chen; Xin-Yu Di; Zhong-Jian Wang; Li Liu; Xiao-Dong Liu
Journal:  Acta Pharmacol Sin       Date:  2016-05-16       Impact factor: 6.150

9.  P-glycoprotein and multidrug resistance-associated protein 2 are oppositely altered in brain of rats with thioacetamide-induced acute liver failure.

Authors:  Shi Jin; Xin-Ting Wang; Li Liu; Dan Yao; Can Liu; Mian Zhang; Hai-Fang Guo; Xiao-Dong Liu
Journal:  Liver Int       Date:  2012-08-26       Impact factor: 5.828

10.  Altered Function and Expression of ABC Transporters at the Blood-Brain Barrier and Increased Brain Distribution of Phenobarbital in Acute Liver Failure Mice.

Authors:  Li Liu; Mingxing Miao; Yang Chen; Zhongjian Wang; Binbin Sun; Xiaodong Liu
Journal:  Front Pharmacol       Date:  2018-03-06       Impact factor: 5.810

View more
  2 in total

1.  Vascular network expansion, integrity of blood-brain interfaces, and cerebrospinal fluid cytokine concentration during postnatal development in the normal and jaundiced rat.

Authors:  Sandrine Blondel; Nathalie Strazielle; Amel Amara; Rainui Guy; Christine Bain; Alix Rose; Laurent Guibaud; Claudio Tiribelli; Silvia Gazzin; Jean-François Ghersi-Egea
Journal:  Fluids Barriers CNS       Date:  2022-06-07

2.  Bile Duct Ligation Impairs Function and Expression of Mrp1 at Rat Blood-Retinal Barrier via Bilirubin-Induced P38 MAPK Pathway Activations.

Authors:  Ping Li; Yiting Yang; Zijin Lin; Shijin Hong; Ling Jiang; Han Zhou; Lu Yang; Liang Zhu; Xiaodong Liu; Li Liu
Journal:  Int J Mol Sci       Date:  2022-07-11       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.